Fig. 4From: A new anti-glioma therapy, AG119: pre-clinical assessment in a mouse GL261 glioma modelCytotoxic effect of AG119 on temozolomide (TMZ)-resistant cells. Cells, U251 (TMZ-sensitive; MGMTā) and T98G (TMZ-resistant; MGMT+), were treated with AG119 or TMZ for 48Ā h and viability determined with Presto Blue. Data are mean IC50 values (Ī¼M)āĀ±āSEM, nā=ā4ā9 independent experimentsBack to article page